HumeCare+ Review
Best for: People who want GLP-1 weight loss with real-time body-composition tracking to protect muscle
HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company. It pairs clinician-prescribed compounded semaglutide with continuous body-composition tracking via an included Hume Pod device, so you can see whether you are losing fat rather than muscle. Plans start from $199/mo billed monthly (cancel anytime) and include the medication plus the device. The state-availability list is not published, and the prescribing medical group and pharmacy partner are not named on the marketing site.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
HumeCare+ is a solid telehealth option with balanced features and pricing.
HumeCare+ at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $199/mo (Program from $199/mo, billed monthly; includes the GLP-1 medication plus a free Hume Pod body-composition device)
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored HumeCare+
Each dimension is scored algorithmically from HumeCare+’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.9/10At $199/mo, HumeCare+ runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
7.7/10HumeCare+ offers semaglutide, the GLP-1 with the deepest published weight-loss evidence base.
User Experience15%
7.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-20).
Accessibility10%
6.2/10HumeCare+'s exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10HumeCare+ provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this HumeCare+ review
Last checked 2026-06-20- Confirmed current pricing across 1 dose/plan tier
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications HumeCare+ offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Program from $199/mo, billed monthly; includes the GLP-1 medication plus a free Hume Pod body-composition device
Ready to get started?
Plans and promotions change often — check HumeCare+'s current pricing and active discounts before you decide.
What we like
- Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
- Includes a Hume Pod body-composition device at no extra cost
- From $199/mo, billed monthly, cancel anytime
- Backed by Hume Health, an established body-composition scale brand
- Clinician-prescribed and monitored with weekly tracking
Watch-outs
- Final medication pricing is gated behind an intake quiz
- Only semaglutide is shown on the marketing site (tirzepatide not confirmed)
- Prescribing medical group and pharmacy partner not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Is HumeCare+ worth it? Our verdict
HumeCare+ positions itself around one thing: People who want GLP-1 weight loss with real-time body-composition tracking to protect muscle. It runs $199/month — a premium to the category, so the extras need to justify it.
How much HumeCare+ actually costs
- Compounded semaglutide — $199/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so HumeCare+'s standing rate sits at the premium end.
Medications: what HumeCare+ prescribes
HumeCare+ prescribes semaglutide (the active drug in Wegovy and Ozempic) — one of the most clinically proven GLP-1 options. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who HumeCare+ is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
HumeCare+ costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
Ready to start with HumeCare+?
Starting at $199/month. See current pricing and start your free consultation.
Alternatives to HumeCare+
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HumeCare+ review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Ready to start with HumeCare+?
Starting at $199/month. See current pricing and start your free consultation.